Cargando…

Insights into Mucopolysaccharidosis I from the structure and action of α-L-Iduronidase

Mucopolysaccharidosis type I (MPS I), caused by mutations in the gene encoding α-L-iduronidase (IDUA), is one of approximately 70 genetic disorders collectively known as the lysosomal storage diseases. To gain insight into the basis for MPS I, we have crystallized human IDUA produced in an Arabidops...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bie, Haiying, Yin, Jiang, He, Xu, Kermode, Allison R., Goddard-Borger, Ethan D., Withers, Stephen G., James, Michael N. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954775/ https://www.ncbi.nlm.nih.gov/pubmed/24036510 http://dx.doi.org/10.1038/nchembio.1357

Ejemplares similares

α-L-iduronidase therapy for mucopolysaccharidosis type I
por: Tolar, Jakub, et al.
Publicado: (2008)

Case Report: Mucopolysaccharidosis Type I Treatment With α-L-Iduronidase Replacement Therapy
por: Li, Ying, et al.
Publicado: (2022)

Three novel α-L-iduronidase mutations in 10 unrelated Chinese mucopolysaccharidosis type I families
por: Sun, Luning, et al.
Publicado: (2011)

Enzyme replacement with transferrin receptor-targeted α-L-iduronidase rescues brain pathology in mucopolysaccharidosis I mice
por: Kida, Sachiho, et al.
Publicado: (2023)

New Irreversible α‐l‐Iduronidase Inhibitors and Activity‐Based Probes
por: Artola, Marta, et al.
Publicado: (2018)

Mucopolysaccharidosis type I: molecular characteristics of two novel alpha-L-iduronidase mutations in Tunisian patients
por: Chkioua, Latifa, et al.
Publicado: (2011)

A novel p.E276K IDUA mutation decreasing α-L-iduronidase activity causes mucopolysaccharidosis type I
por: Prommajan, Korrakot, et al.
Publicado: (2011)

Mesenchymal Stem Cells Do Not Prevent Antibody Responses against Human α-L-Iduronidase when Used to Treat Mucopolysaccharidosis Type I
por: Martin, Priscila Keiko Matsumoto, et al.
Publicado: (2014)

Report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I
por: Kwak, Min Jung, et al.
Publicado: (2016)

Comment on “report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I”
por: Poletto, Edina, et al.
Publicado: (2018)

Genotypic and bioinformatic evaluation of the alpha-l-iduronidase gene and protein in patients with mucopolysaccharidosis type I from Colombia, Ecuador and Peru
por: Pineda, Tatiana, et al.
Publicado: (2014)

Alpha‐L‐iduronidase deficiency: A novel mutation resulting in severe early presentation of Mucopolysaccharidosis type I and literature review of the molecular basis
por: Al Zaabi, Nuha Nasser, et al.
Publicado: (2022)

Characterization and downstream mannose phosphorylation of human recombinant α-L-iduronidase produced in Arabidopsis complex glycan-deficient (cgl) seeds
por: He, Xu, et al.
Publicado: (2013)

A Simple and Rapid Method Based on Liquid Chromatography-Tandem Mass Spectrometry for the Measurement of α-L-Iduronidase Activity in Dried Blood Spots: An Application to Mucopolysaccharidosis I (Hurler) Screening
por: Yang, Jeong Soo, et al.
Publicado: (2015)

Development of a newborn screening tool for mucopolysaccharidosis type I based on bivariate normal limits: Using glycosaminoglycan and alpha‐L‐iduronidase determinations on dried blood spots to predict symptoms
por: Langan, Thomas J., et al.
Publicado: (2020)

Quantitative Analysis of α-L-Iduronidase Expression in Immunocompetent Mice Treated with the Sleeping Beauty Transposon System
por: Aronovich, Elena L., et al.
Publicado: (2013)

Identification of a novel fusion Iduronidase with improved activity in the cardiovascular system
por: Kim, Sarah, et al.
Publicado: (2022)

Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial
por: Giugliani, Roberto, et al.
Publicado: (2018)

Mucopolysaccharidosis Type I
por: Kubaski, Francyne, et al.
Publicado: (2020)

Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Human Alpha-L-Iduronidase in Rhesus Macaques
por: Hordeaux, Juliette, et al.
Publicado: (2018)

Four cellulose-active lytic polysaccharide monooxygenases from Cellulomonas species
por: Li, James, et al.
Publicado: (2021)

Genotype‐phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry
por: Clarke, Lorne A., et al.
Publicado: (2019)

Brassica rapa hairy root based expression system leads to the production of highly homogenous and reproducible profiles of recombinant human alpha‐L‐iduronidase
por: Cardon, Florian, et al.
Publicado: (2018)

Aortic Root Dilatation in Mucopolysaccharidosis I–VII
por: Bolourchi, Meena, et al.
Publicado: (2016)

Open issues in Mucopolysaccharidosis type I-Hurler
por: Parini, Rossella, et al.
Publicado: (2017)

Potent Human α-Amylase Inhibition by the β-Defensin-like Protein Helianthamide
por: Tysoe, Christina, et al.
Publicado: (2016)

Cardiac abnormalities in adults with the attenuated form of mucopolysaccharidosis type I
por: Soliman, O. I. I., et al.
Publicado: (2007)

Short stature as a presenting symptom of attenuated Mucopolysaccharidosis type I: case report and clinical insights
por: Martins, Ana Maria, et al.
Publicado: (2018)

Arterial Pathology in Canine Mucopolysaccharidosis-I and Response to Therapy
por: Lyons, Jeremiah A., et al.
Publicado: (2011)

Airway-Related Symptoms and Surgeries in Patients With Mucopolysaccharidosis I
por: Arn, Pamela, et al.
Publicado: (2015)

Immune tolerance induction for laronidase treatment in mucopolysaccharidosis I
por: Giugliani, Roberto, et al.
Publicado: (2017)

Phenotype prediction for mucopolysaccharidosis type I by in silico analysis
por: Ou, Li, et al.
Publicado: (2017)

Cognitive Abilities of Dogs with Mucopolysaccharidosis I: Learning and Memory
por: Provoost, Lena, et al.
Publicado: (2020)

Molecular Analysis of Vietnamese Patients with Mucopolysaccharidosis Type I
por: Can, Ngoc Thi Bich, et al.
Publicado: (2021)

Mucopolysaccharidosis Type I in Mexico: Case-Based Review
por: Cantú-Reyna, Consuelo, et al.
Publicado: (2023)

Structure of sulfamidase provides insight into the molecular pathology of mucopolysaccharidosis IIIA
por: Sidhu, Navdeep S., et al.
Publicado: (2014)

Mucopolysaccharidosis VI
por: Valayannopoulos, Vassili, et al.
Publicado: (2010)

Diagnosing mucopolysaccharidosis IVA
por: Wood, Timothy C., et al.
Publicado: (2013)

Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB
por: Wilkinson, Fiona L., et al.
Publicado: (2012)

Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I
por: Thomas, Janet A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_3bfet16b4rnudi896t9jp8bukf